SUBSEQUENT ALLOTRANSPLANT IN ADULTS WITH ADVANCED ACUTE LYMPHOBLASTIC LEUKEMIA AFTER CD19 CAR-T-CELL THERAPY: A MULTI-CENTER RANDOMIZED CONTROLLED TRIAL

EHA Library, Jia Chen, 420459

CAMPUS ALL MULTICENTER STUDY ON OUTCOME OF 421 ADULT PH-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED IN REAL-LIFE WITH AN INTENSIVE PROGRAM INSPIRED TO THE GIMEMA LAL1913 CLINICAL TRIAL

EHA Library, Davide Lazzarotto, 420460

AUGMENTED USE OF L-ASPARAGINASE MARKEDLY IMPROVES THE TREATMENT RESULT OF AYA ALL PATIENTS: RESULT OF PROSPECTIVE MRD 2014 STUDY CONDUCTED BY FUKUOKA BLOOD AND MARROW TRANSPLANTATION GROUP (FBMTG)

EHA Library, Koji Nagafuji, 420461

PONATINIB, CHEMOTHERAPY AND TRANSPLANTATION FOR NEWLY DIAGNOSED ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ ALL). FINAL RESULTS OF THE PHASE 2 PONALFIL TRIAL

EHA Library, Josep Maria Ribera, 420462

OUTCOME PREDICTORS FOR PATIENTS AGED 55 YEARS AND OLDER WITH ACUTE LYMPHOBLASTIC LEUKEMIA: A RETROSPECTIVE STUDY FROM THE HARMONY BIG DATA PLATFORM

EHA Library, Amin Turki, 420463

BUSULFAN PLUS CYCLOPHOSPHAMIDE VS. TOTAL BODY IRRADIATION PLUS CYCLOPHOSPHAMIDE FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE T LYMPHOBLASTIC LEUKEMIA

EHA Library, Yifan Shen, 420464

EFFICACY AND SAFETY ANALYSIS OF HYPER-CVAD AND SEQUENTIAL BLINATUMOMAB FOR ACUTE LYMPHOCYTIC LEUKEMIA AND CHRONIC MYELOID LEUKEMIA BLAST CRISIS PATIENTS

EHA Library, Qiuling Wu, 420465

EFFICACY AND TOLERANCE OF MODIFIED HYPERCVAD, BLINATUMOMAB, AND TKI COMBINATION AS A TREATMENT FOR RELAPSED OR REFRACTORY PH+ B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Gaétan BASILE, 420466

MRD MONITORING IN CHILDHOOD PH-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: PROGNOSTIC SIGNIFICANCE AND CORRELATION BETWEEN MULTIPARAMETER FLOW CYTOMETRY AND RT-QPCR

EHA Library, Jun Li, 420467

RISK ASSESSMENT OF CANCER THERAPY-RELATED CARDIOVASCULAR TOXICITY: A PROGNOSTIC FACTOR IN ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA.

EHA Library, Laura Elena Valdovinos-Elizalde, 420468

ACUTE LYMPHOBLASTIC LEUKAEMIA IN PATIENTS TREATED WITH LENALIDOMIDE IN MULTIPLE MYELOMA: A SAFETY META-ANALYSIS COMBINED WITH A RETROSPECTIVE STUDY OF THE WHO’S PHARMACOVIGILANCE DATABASE

EHA Library, PIERRE MARIE MORICE, 420469

OCCULT CENTRAL NERVOUS SYSTEM LOCALIZATION IN ADULT PATIENTS AFFECTED WITH ACUTE   LYMPHOBLASTIC LEUKEMIA. A CAMPUS ALL PROSPECTIVE STUDY.

EHA Library, Maria Ilaria DEL PRINCIPE, 420470

RECOMBINANT ERWINIA ASPARAGINASE (JZP458) IN ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA (ALL/LBL): POST HOC ANALYSIS OF ADVERSE EVENTS OF INTERESTS FROM AALL1931

EHA Library, Luke Maese, 420471

PRELIMINARY EFFECT OF ENHANCED LYMPHODEPLETION (ELD) ON WU-CART-007 IN TALL/LBL

EHA Library, Ibrahim Aldoss, 420472

BLINATUMOMAB INDUCTION THERAPY FOLLOWING REDUCED-DOSE CHEMOTHERAPY IN NEWLY DIAGNOSED ADULT PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA:MULTICENTRE, SINGLE ARM, PHASE 2 STUDY

EHA Library, Jing Lu, 420473

ASCIMINIB FOR RELAPSED OR REFRACTORY PHILADELPHIA POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ ALL) AND LYMPHOID BLAST CRISIS CHRONIC MYELOGENOUS LEUKEMIA (LBC-CML).

EHA Library, Mathilde CHANUT, 420474

A FULL PEDIATRIC REGIMEN FOR ADULT PATIENTS WITH PHILADELPHIA NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA ACHIEVES EXCELLENT OUTCOME WITH ACCEPTABLE TOXICITY.

EHA Library, Michela Frello, 420475

PROFILE AND PROGNOSTIC SIGNIFICANCE OF RAS PATHWAY ALTERATIONS IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Jiawang Ou, 420476

BREXUCABTAGENE AUTOLEUCEL (BREXU-CEL) AS CONSOLIDATION TREATMENT IN ADULTS WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH MARROW BLASTS <5%, INCLUDING PATIENTS (PTS) WITH NGS MRD NEGATIVE DISEASE

EHA Library, Nitin Jain, 420477

PROGNOSTIC FACTORS IMPACTING POST-TRANSPLANT OUTCOMES IN ADULT T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A REGISTRY-BASED STUDY BY THE EBMT ACUTE LEUKEMIA WORKING PARTY

EHA Library, Jean El Cheikh, 420478

ALLOGENEIC STEM CELL TRANSPLANTATION DOES NOT SUGGEST IMPROVING OVERALL SURVIVAL IN ADOLESCENT AND YOUNG ADULT WITH PHILADELPHIA CHROMOSOME ACUTE LYMPHOBLASTIC LEUKEMIA WITH UNDETECTABLE BCR::ABL1.

EHA Library, Talha Badar, 420479

BLINATUMOMAB ALTERNATING WITH LOW-INTENSITY CHEMOTHERAPY (LIC) IN OLDER ADULTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): SAFETY RUN-IN FOLLOW-UP FOR THE PHASE 3 GOLDEN GATE STUDY

EHA Library, Elias Jabbour, 420480

TREATMENT AND OUTCOMES OF OLDER PATIENTS WITH PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA. A NATIONWIDE CAMPUS ALL REAL-LIFE STUDY ON 302 PATIENTS

EHA Library, Marco Cerrano, 420481

OBECABTAGENE AUTOLEUCEL (OBE-CEL, AUTO1) FOR RELAPSED/REFRACTORY ADULT B CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL): THE IMPACT OF INOTUZUMAB-CONTAINING BRIDGING THERAPY ON TREATMENT OUTCOMES

EHA Library, Jae H. Park, 420482

IMPACT OF NGS MRD AND CLONAL EVOLUTION ON CLINICAL PROGNOSIS IN PEDIATRIC PH+ ALL PATIENTS

EHA Library, Lixian Chang, 420483

AUTOLOGOUS CD19-DIRECTED CAR T CELLS PRODUCED BY NOVEL BEDSIDE-MANUFACTURE PLATFORM EXHIBIT SAFETY AND EFFICACY IN R/R B-ALL

EHA Library, Shiqi Li, 420484

FLOW-CYTOMETRIC MRD DETECTION IN PEDIATRIC T-ALL: A CONSENSUS-BASED STANDARDIZED APPROACH

EHA Library, Michaela Reiterová, 420485

IMPACT OF PROPHYLACTIC CRANIAL IRRADIATION ON OUTCOMES OF ADULTS ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH PEDIATRIC INSPIRED PROTOCOL

EHA Library, Mohammad Alwadi, 420486

SHORT-TERM BLINATUMOMAB BRIDGING ALLO-HSCT IN HR B-ALL

EHA Library, Huizhu Kang, 420487

REAL-WORLD UTILIZATION OF BLINATUMOMAB IN ADULT AND PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN FRANCE: RESULTS FROM THE ATHENA STUDY

EHA Library, Thomas Cluzeau, 420488

TARGETED- AND IMMUNO-BASED THERAPIES FOR ADULTS WITH TP53-MUTATED ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Jose Tinajero, 420489

DE-INTENSIFYING POST-INDUCTION THERAPY FOR PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKAEMIA, GOOD RISK GENETICS AND INTERMEDIATE MRD AT THE END OF INDUCTION.

EHA Library, Anthony Moorman, 420490

COMBINATION OF THIRD GENERATION TKI OLVEREMBATINIB AND CHEMOTHERAPY OR BLINATUMOMAB FOR NEW DIAGNOSED ADULT PH+ ALL PATIENTS

EHA Library, Junjie Chen, 420491

HEM-ISMART: AN INTERNATIONAL PROOF OF CONCEPT THERAPEUTIC STRATIFICATION TRIAL OF MOLECULAR ANOMALIES IN RELAPSED OR REFRACTORY HEMATOLOGICAL MALIGNANCIES IN CHILDREN

EHA Library, Andrej Lissat, 420492

FIVE-YEAR OUTCOME OF CD19 COMBINED WITH CD22 CAR-T CELL THERAPY IN B-ALL PATIENTS RELAPSED AFTER ALLO-TRANSPLANTATION

EHA Library, Shuangyou Liu, 420493

COMBINATORIAL EXPRESSION PATTERNS OF SURFACE ANTIGENS IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA BLASTS

EHA Library, Naeem Khan, 420494

PATHOPHYSIOLOGY OF DIFFERENTIATION SYNDROME IN ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Luca Guarnera, 420495

RUNX1 STOP-LOSS MUTATIONS DEFINE A DISTINCT PROGNOSTIC SUBSET WITHIN RUNX1-MUTATED ACUTE MYELOID LEUKAEMIA

EHA Library, Radha Ramanan, 420496

CD34+CD38- LEUKEMIA STEM CELLS ARE ASSOCIATED WITH PROGNOSIS IN NON-INTENSIVELY TREATED ACUTE MYELOID LEUKEMIA

EHA Library, Tom Reuvekamp, 420497

A CD8+ T CELL RELATED IMMUNE SCORE PREDICTS SURVIVAL AND REFINES THE RISK ASSESSMENT IN ACUTE MYELOID LEUKEMIA

EHA Library, Zeyi Li, 420498

FLT3-ITD INDUCES IMMUNE ESCAPE IN AML VIA UP-REGULATING CD47 EXPRESSION AND DECREASED PHAGOCYTIC ABILITY OF MACROPHAGES

EHA Library, Liang Yang, 420499

THE NOVEL TYROSINE KINASE INHIBITOR AD80 EXHIBITS POTENT ANTINEOPLASTIC EFFECTS ON AML MODELS WITH FLT3-ITD MUTATIONS

EHA Library, Lívia Bassani Lins de Miranda, 420500

ERRΑ ROLE AS THERAPEUTIC TARGET IN ACUTE MYELOID LEUKEMIA

EHA Library, wonhyoung Seo, 420501

A CLL1 AND CD38 DUAL TARGETING FASTCAR T THERAPY FOR ACUTE MYELOID LEUKEMIA

EHA Library, Lianjun Shen, 420502

TARGETING THE LEUKAEMIC BONE MARROW PROTECTIVE NICHE MAY INCREASE THE SENSITIVITY OF ACUTE MYELOID LEUKAEMIA (AML) TO STANDARD CHEMOTHERAPY.

EHA Library, Ahmed Elmarghany, 420503

THERAPEUTIC VULNERABILITY TO PARP INHIBITION DRIVEN BY TARGETED BASE EXCISION REPAIR IN LEUKEMIA

EHA Library, John Brabson, 420504

PROGNOSTIC RELEVANCE OF MEASURABLE RESIDUAL MUTATED IDH2 AFTER INTENSIVE INDUCTION CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Lena Cimbalnik, 420505

SEX DISPARITIES IN GENETIC LANDSCAPE OF ACUTE MYELOID LEUKEMIA: A COMPREHENSIVE ANALYSIS USING THE HARMONY CONSORTIUM DATASET

EHA Library, Jesse Tettero, 420506

THE PROGNOSTIC LNCRNA FAM30A REGULATES THE MUSASHI2-RUNX1 AXIS AND CONFERS STEMNESS, CHEMORESISTANCE AND ENGRAFTMENT TO AML CELLS

EHA Library, Jaime Calvo Sánchez, 420507

TARGETING MYC BY DEGRADATION REWIRES METABOLOMICS AND INDUCES CELL KILL IN TP53 MUTANT ACUTE MYELOID LEUKEMIAS

EHA Library, Michael Andreeff, 420508

KK2845, A PBD DIMER-CONTAINING ANTIBODY-DRUG CONJUGATE TARGETING TIM-3-EXPRESSING LEUKEMIA STEM CELLS OF AML

EHA Library, Jian Zou, 420509

ABERRANT EXPRESSION OF SLAMF6 CONSTITUTES A NOVEL AND TARGETABLE IMMUNE ESCAPE MECHANISM IN ACUTE MYELOID LEUKEMIA

EHA Library, Carl Sandén, 420510

RUNX1-ETO AND CBFB-MYH11 CONVERGE ON ABERRANT ACTIVATION OF BCAT1 TO CONFER A THERAPEUTIC VULNERABILITY IN CORE BINDING FACTOR-ACUTE MYELOID LEUKEMIA

EHA Library, Siyang Wang, 420511

CHARACTERIZATION OF LEUKEMIC STEM CELLS IN FLT3-ITD-POSITIVE ACUTE MYELOID LEUKEMIA: LEUKEMIA INITIATING CAPACITY AND TARGETED TREATMENT

EHA Library, Tiziana Ottone, 420512

TARGETED RNA SEQUENCING FREQUENTLY IDENTIFIES HIGH-RISK FUSION GENES IN YOUNGER ADULTS WITH OTHERWISE INTERMEDIATE-RISK AML AND ISOLATED FLT3-ITD

EHA Library, Nicola Potter, 420513

VENETOCLAX INDUCES MITOCHONDRIAL ROS-MEDIATED APOPTOSIS VIA STAT3/ BCL2/ BECLIN-1 AXES TO OVERCOME ARSENIC RESISTANCE IN ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Deepshikha Dutta, 420514

ENHANCING NKG2DL-MEDIATED IMMUNOGENICITY OF ACUTE MYELOID LEUKEMIA CELLS BY GATA2 SUPPRESSION AND INDUCTION OF MYELOID DIFFERENTIATION TO IMPROVE NK CELL THERAPY

EHA Library, Saskia Rudat, 420515

TRMT5 METHYLATES DISTINCT MITOCHONDRIAL TRNAS TO SUSTAIN THE DYNAMIC UPREGULATION OF OXPHOS FOR SURVIVAL AND DRUG TOLERANCE IN AML

EHA Library, Michael Kienhöfer, 420516

CCTX-001, A FIRST IN CLASS AUTOLOGOUS ANTI-IL-1RAP CAR T-CELL THERAPY FOR THE TREATMENT OF RELAPSED/REFRACTORY AML

EHA Library, Nicolas Boissel, 420517

BIOMARKER RESULTS OF THE PHASE 1 DOSE ESCALATION TRIAL OF THE HLA-A2-WT1 CD3 T-CELL BISPECIFIC (TCB) ANTIBODY RO7283420 (RG6007) IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML)

EHA Library, Marion Subklewe, 420518

SINGLE CELL SEQUENCING REVEALED THE SIGNIFICANT ROLE OF HOPX IN CONTRIBUTING TO CHEMO-RESISTANCE IN ACUTE MYELOID LEUKEMIA

EHA Library, Gelan Zhu, 420519

OVERCOMING AGGRESSIVE EMT-ASSOCIATED PHENOTYPES IN ACUTE MYELOID LEUKEMIA CELLS WITH KMT2A-MLLT3 REARRANGEMENTS THROUGH THE MODULATION OF MICRORNA-204

EHA Library, Liam MacPhee, 420520

SINGLE-CELL METABOLIC ANALYSIS AND EXTRACELLULAR VESICLE PROFILING IMPROVE RISK STRATIFICATION AND REVEAL NOVEL METABOLIC VULNERABILITIES IN ACUTE MYELOID LEUKEMIA

EHA Library, Dorian Forte, 420521

IDENTIFICATION OF PREDICTIVE BIOMARKERS AND COMBINATORIAL TREATMENTS FOR AML USING AN ADVANCED CRISPR/CAS9 SCREENING PLATFORM

EHA Library, Johannes Schmoellerl, 420522

ABSENCE OF STAT3Β CONTRIBUTES TO ADVERSE OUTCOME IN ACUTE MYELOID LEUKEMIA BY ENHANCING THE INTERFERON RESPONSE

EHA Library, Sophie Edtmayer, 420523

MULTICENTER RETROSPECTIVE OBSERVATORY OF ACUTE MYELOID LEUKEMIA PATIENTS WITH NUP98 REARRANGEMENT. A STUDY FROM THE ALFA-FILO FRENCH AML INTERGROUP.

EHA Library, Benoît Ducourneau, 420524

MLLT1/3 TARGETED AGENTS AS NOVEL INHIBITORS OF THE SUPER-ELONGATION COMPLEX (SEC) TO TREAT MOLECULARLY DEFINED ACUTE LEUKEMIA INCLUDING MENIN-INHIBITOR RESISTANT AND REFRACTORY DISEASE.

EHA Library, Alison Maloney, 420525

BRD4 DEGRADATION AS A NOVEL STRATEGY TO OVERCOME INTRINSIC, ACQUIRED, NICHE-INDUCED AND CHECKPOINT-MEDIATED RESISTANCE IN AML AND ALL

EHA Library, Karin Bauer, 420527

INVESTIGATION OF THE REGULATORS OF NUP98 FUSION ONCOPROTEIN HOMEOSTASIS

EHA Library, Ecem Kirkiz, 420528

IDENTIFICATION OF ZFP91 AS THE MASTER TRANSCRIPTION FACTOR FOR EVI1 GENE EXPRESSION IN MYELOID LEUKEMIA

EHA Library, Hiroki Hayashida, 420529

(R)-WAC-224, A NOVEL ANTICANCER QUINOLONE AND VENETOCLAX PLUS AZACITIDINE OVERCOME VENETOCLAX-RESISTANT AML VIA DOWNREGULATION OF MCL-1

EHA Library, Hiroshi Ureshino, 420530

PROTEOMIC ANALYSIS BY OLINK INFLAMMATION PLATFORM PREDICTED THE CHEMORESITANCE IN AML UNDER 7+3

EHA Library, Ling-Chiao Teng, 420531

SINGLE-CELL COMPUTER VISION UNVEILS DISCRIMINATIVE FEATURES OF LATENT CELLULAR MORPHOLOGY IN MYELOID CLONAL HEMATOPOIESIS

EHA Library, Helong Zhao, 420532

INTERPLAY BETWEEN MACROPHAGES AND AML BLASTS IN PEDIATRIC ACUTE MYELOID LEUKEMIA

EHA Library, Alicia Perzolli, 420533

ENHANCING THE EFFICACY OF P53-Y220C REACTIVATOR PC14586 BY COMBINATION WITH MDM2 OR BCL-2 INHIBITORS IN TP53-Y220C AML

EHA Library, Bing Carter, 420534

ACUTE MYELOID LEUKEMIA-MODIFIED BONE MARROW ENDOTHELIAL PROGENITOR CELLS COULD BE REMODELED TO FACILITATE RECOVERY OF NORMAL HEMATOPOIESIS AFTER COMPLETE REMISSION

EHA Library, Tong Xing, 420535

GENOMIC LANDSCAPE AND CLONAL HEMATOPOIESIS DYNAMICS IN PATIENTS WITH EPITHELIAL OVARIAN CANCER (EOC) DURING PARP INHIBITORS TREATMENT: PRELIMINARY RESULTS OF A PROSPECTIVE LONGITUDINAL STUDY

EHA Library, Elisabetta Todisco, 420536

CD37 IS A RELEVANT TARGET FOR AML AND MDS TREATMENT BY DEBIO 1562M ANTIBODY DRUG CONJUGATE (ADC)

EHA Library, Lisa Ivanschitz, 420537

MUTANT U2AF1-INDUCED MIS-SPLICING OF MRNA TRANSLATION GENES CONFERS RESISTANCE TO CHEMOTHERAPY IN ACUTE MYELOID LEUKEMIA

EHA Library, Peng Jin, 420538

EXPLORING DOSE-RESPONSE RELATIONSHIP OF A NOVEL CD123 NK CELL ENGAGER SAR443579 IN ACUTE MYELOID LEUKEMIA (AML) MODELS

EHA Library, Angela Virone-Oddos, 420539

THE DIFFERENTIAL ROLE OF STAT3 AND STAT5 FACTORS IN LEUKEMIC TRANSFORMATION FROM MDS TO AML

EHA Library, Eirini Sofia Fasouli, 420540

IDENTIFICATION OF FUNCTIONALLY ACTIVE AND ESSENTIAL ENHANCERS IN ACUTE MYELOID LEUKAEMIA

EHA Library, Bettina Wingelhofer, 420541

THE BISPECIFIC INNATE CELL ENGAGER AFM28 INDUCES POTENT ANTI-TUMOR ACTIVITY AGAINST AML IN A XENOGRAFT MOUSE MODEL AND IN A BONE MARROW NICHE IN VITRO MODEL

EHA Library, Ioanna Tsoukala, 420542

SINGLE-CELL GUIDED IMMUNE DECONVOLUTION IDENTIFIES CHEMOTHERAPY-ASSOCIATED ALTERATIONS OF THE BONE MARROW IMMUNE MICROENVIRONMENT IN PEDIATRIC AML

EHA Library, Joost Koedijk, 420543

TRANSCRIPTION FACTOR MYBL2 ACTS AS A MOLECULAR SWITCH BETWEEN PROLIFERATION AND SENESCENCE IN ACUTE MYELOID LEUKEMIA

EHA Library, Sandra Schuster, 420544

SINGLE-CELL TRANSCRIPTOMICS REVEALS T CELL EXHAUSTION IN SUPPRESSIVE MARROW IMMUNE MICROENVIRONMENT OF RESIDUAL DISEASE POSITIVE PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER ALLOGENEIC TRANSPLANTATION

EHA Library, Siqi Li, 420545

MOLECULAR BACKTRACKING OF LEUKEMIC CELLS IN CRYOPRESERVED OVARIAN TISSUE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Augustin Boudry, 420546

CEBPA MUTATIONAL SPECTRUM AND ITS CLINICAL IMPLICATIONS IN AML VERSUS MDS – RETROSPECTIVE REAL WORLD STUDY OF CEBPA-MUTATED PATIENTS

EHA Library, Katrin Schweneker, 420547

INDUCTION OF AML CELL DEATH AND DIFFERENTIATION USING HOXA9/DNA BINDING INHIBITORS DB818 AND DB1055 AS A POTENTIAL THERAPEUTIC OPTION FOR AML PATIENTS.

EHA Library, Marie-Helene DAVID-CORDONNIER, 420548

M6A RNA MODIFICATION INITIATED BY METTL3 PROMOTES FOXO3 EXPRESSION TO INDUCE ANTHRACYCLINE RESISTANCE IN ACUTE MYELOID LEUKEMIA CELLS

EHA Library, Xiawei Zhang, 420549

INHIBITION OF PINK1-MEDIATED MITOPHAGY POTENTIATES VENETOCLAX ACTIVITY IN ACUTE MYELOID LEUKEMIA.

EHA Library, Romain Vazquez, 420550

UBE2Q1 IMPAIRS ANTIGEN PRESENTATION IN AML

EHA Library, Xiaoxuan Yu, 420551

CLINICAL SIGNIFICANCE OF NPM1 SUBGROUPS IN THE DIAGNOSIS OF AML PATIENTS

EHA Library, Wencke Walter, 420552

CSF1R MARKS A SUBSET OF FETAL LMPP WITH ACUTE MYELOID LEUKEMIA PROPAGATION PROPERTIES IN A MLL-AF9 MOUSE MODEL

EHA Library, Giuseppina Camiolo, 420553

UNRAVELING CLONAL EVOLUTION AND MECHANISMS OF TREATMENT RESISTANCE IN MURINE KMT2A-REARRANGED LEUKEMIA WITH SUBCLONAL FLT3N676K

EHA Library, Ton Falqués-Costa, 420554

NOVEL VHH-BASED CAR-T CELLS AGAINST CD33 WITH DIFFERENT AFFINITIES PRESENT IMPROVED EFFICACY FOR THE TREATMENT OF AML

EHA Library, Franco Bernasconi Bisio, 420555

THE TGFΒ SIGNALING PARADOX IN AML: A SYSTEMATIC CRISPRI-BASED SCREENING APPROACH TO OVERCOME DRUG RESISTANCE

EHA Library, Elahe Rahimian, 420556

CCRL2 PROMOTES MALIGNANT CELL GROWTH AND INDUCES STAT1 SIGNALING IN ERYTHROLEUKEMIA

EHA Library, Nour Naji, 420557

SELECTIVE ABLATION OF CXCR4+ AML PATIENT CELLS IN VITRO AND INHIBITION OF LEUKEMIA DISSEMINATION IN VIVO BY A MULTIVALENT MMAE-BASED HUMANIZED NANOCONJUGATE

EHA Library, Annabel Garcia León, 420558

PP2A- BASED THERAPEUTIC STRATEGIES FOR KMT2A-REARRANGED LEUKAEMIA

EHA Library, Maria Teresa Esposito, 420559